Editor's Note
Welcome to the January issue of Sweeteners China News 202301
Market analysis:
- Huakang Pharma plans to buy steam-producing companies with USD75 million.
- Anhui Jinhe: net profit expected to grow over 40% YoY; the EI report of Anhui Jinhe's 5,000 t/a sucralose technology upgrading project was accepted and publicised; Anhui Jinhe was fined USD71,968 (RMB500,000) for the fire.
- Layn's sales of plant extract products increased in 2022, pushing up the revenue of the company.
- Hunan Nutramax plans to raise USD1.76 million through private placement to increase working capital.
Project updates:
- The construction of Kanbo's 10,000 t/a sucralose energy-saving and efficiency-enhancing technology upgrading project was completed.
- The construction of Shandong Qiantai's 500 t/a erythritol project was completed.
- The construction of Yunnan Hejin's 450,000 t/a liquid sugar project was completed.
- The EI report of Nantong Changhai's 6,000 t/a nutritional enhancer resistant dextrin project was accepted and publicised.
- The EI report of Zhongjingmin's pea flour and maltose project was made public.
- Techno's 2,000 t/a sucralose project was completed.
- Dragon-Phoenix Corn's 20,000 t/a erythritol project was completed.
Price update:
In Jan. 2023, demand for acesulfame-K and sucralose was weak during Spring Festival.
Import & Export analysis:
China's mannitol and xylitol exports registered MoM growth in Nov.
In this monthly report, the USD/CNY exchange rate is USD1.00=CNY6.9475 (Source: The People's Bank of China, 3 Jan., 2023). Unless otherwise stated, all prices involved in this report include VAT.
****************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************
Market Analysis
- Huakang Pharma plans to buy steam-producing companies with USD75 million
- Anhui Jinhe: net profit expected to grow over 40% YoY; sucralose technology upgrading project advancing
- Layn continues to ramp up efforts in natural sweetener segment
- Hunan Nutramax intends to raise funds to increase working capital
Company Dynamics
- Kanbo upgrades sucralose production line to increase production and reduce energy consumption
- Shandong Qiantai's erythritol project and Yunnan Hejin's liquid sugar project completed
- Nantong Changhai's resistant dextrin project & Zhongjingmin's pea flour and maltose project
- Techno's 2,000 t/a sucralose project & Dragon-Phoenix Corn's 20,000 t/a erythritol project completed
Price Update
- Ex-works prices of sweeteners in China, Jan. 2023
- Weak demand for acesulfame-K and sucralose during Spring Festival
Import and Export
- Exports of sweeteners and raw materials from China, Nov. 2022
- Exports of mannitol and xylitol increase in Nov.
News in Brief
- China's tariff on sugar for 2023 remains unchanged
- Laibaoyuan plans to produce 300,000 t/a of sugar products
- More than 80% of consumers struggle to identify sugar-free food, survey shows
- Bailong Chuangyuan projects net profit to rise over 38% YoY
- CCGB's revenue expected to grow more than 23% YoY
- Sanyuan Biology granted new patent
- Update on China's sugar production during 2022/23 crushing season
- Inner Mongolia Junye's API and pharmaceutical intermediates project including production of acarbose
- Two projects put on record
- Huacheng Biotech raises over USD14.39 million


